Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis.

Suzuki K, Nagao T, Itabashi M, Hamano Y, Sugamata R, Yamazaki Y, Yumura W, Tsukita S, Wang PC, Nakayama T, Suzuki K.

Nephrol Dial Transplant. 2014 Jun;29(6):1168-77. doi: 10.1093/ndt/gft469. Epub 2013 Dec 5.

PMID:
24319012
2.

Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.

Kanzaki G, Nagasaka S, Higo S, Kajimoto Y, Kanemitsu T, Aoki M, Nagahama K, Natori Y, Tsuboi N, Yokoo T, Shimizu A.

Nephrol Dial Transplant. 2016 Apr;31(4):574-85. doi: 10.1093/ndt/gfv384. Epub 2015 Nov 17.

PMID:
26582929
3.

Proposal of anti-moesin as a novel biomarker for ANCA-associated vasculitis.

Suzuki K, Suzuki K, Nagao T, Nakayama T.

Clin Exp Nephrol. 2013 Oct;17(5):638-41. doi: 10.1007/s10157-013-0861-1. Epub 2013 Sep 27. Review.

PMID:
24072414
4.

Direct activation of glomerular endothelial cells by anti-moesin activity of anti-myeloperoxidase antibody.

Nagao T, Suzuki K, Utsunomiya K, Matsumura M, Saiga K, Wang PC, Minamitani H, Aratani Y, Nakayama T, Suzuki K.

Nephrol Dial Transplant. 2011 Sep;26(9):2752-60. doi: 10.1093/ndt/gfr032. Epub 2011 Mar 5.

PMID:
21378392
5.

Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.

Xu PC, Gou SJ, Yang XW, Cui Z, Jia XY, Chen M, Zhao MH.

BMC Immunol. 2012 Mar 9;13:10. doi: 10.1186/1471-2172-13-10.

7.

Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis.

Hasegawa M, Nishii C, Ohashi A, Tomita M, Nakai S, Murakami K, Nabeshima K, Fujita Y, Ishii J, Hiki Y, Sugiyama S.

Nephron Clin Pract. 2009;113(3):c222-33. doi: 10.1159/000235242. Epub 2009 Aug 18.

PMID:
19690440
8.

Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity.

Nagai M, Hirayama K, Ebihara I, Shimohata H, Kobayashi M, Koyama A.

Nephron Clin Pract. 2011;118(4):c339-45. doi: 10.1159/000323393. Epub 2011 Feb 3.

PMID:
21293157
9.

Vasculitis: Potential role of an anti-moesin autoantibody in MPO-AAV.

Carney EF.

Nat Rev Nephrol. 2014 Feb;10(2):65. doi: 10.1038/nrneph.2013.277. Epub 2013 Dec 24. No abstract available.

PMID:
24375055
10.

Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.

Hirose O, Itabashi M, Takei T, Nitta K.

Mod Rheumatol. 2015 Mar;25(2):230-4. doi: 10.3109/14397595.2014.951113. Epub 2014 Nov 12.

PMID:
25388618
11.

Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.

Yoshida M, Sasaki M, Nakabayashi I, Akashi M, Tomiyasu T, Yoshikawa N, Kojima T, Ohno N, Yamada M.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S28-32.

PMID:
19646343
12.

Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody.

Land J, Rutgers A, Kallenberg CG.

Nephrol Dial Transplant. 2014 Apr;29(4):739-45. doi: 10.1093/ndt/gft416. Epub 2014 Jan 6. Review.

PMID:
24398891
13.

Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis.

Gou SJ, Xu PC, Chen M, Zhao MH.

PLoS One. 2013;8(4):e60530. doi: 10.1371/journal.pone.0060530. Epub 2013 Apr 5.

14.

Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel disease.

Romas E, Paspaliaris B, d'Apice AJ, Elliott PR.

Aust N Z J Med. 1992 Dec;22(6):652-9.

PMID:
1489288
15.

Increased concentrations of antibody against heat shock protein in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody positive microscopic polyangiitis.

Komiya I, Arimura Y, Nakabayashi K, Yamada A, Osaki T, Yamaguchi H, Kamiya S.

Microbiol Immunol. 2011 Aug;55(8):531-8. doi: 10.1111/j.1348-0421.2011.00351.x.

16.

Granulocyte colony stimulating factor exacerbates antineutrophil cytoplasmic antibody vasculitis.

Freeley SJ, Coughlan AM, Popat RJ, Dunn-Walters DK, Robson MG.

Ann Rheum Dis. 2013 Jun;72(6):1053-8. doi: 10.1136/annrheumdis-2012-202160. Epub 2012 Oct 19.

PMID:
23087180
17.

[The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].

Zhou XL, Zheng MJ, Shuai ZW, Zhang L, Zhang MM, Chen SY.

Zhonghua Nei Ke Za Zhi. 2017 Jun 1;56(6):427-432. doi: 10.3760/cma.j.issn.0578-1426.2017.06.008. Chinese.

PMID:
28592042
18.

Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass.

Cambridge G, Williams M, Leaker B, Corbett M, Smith CR.

Ann Rheum Dis. 1994 Jan;53(1):24-9.

19.

Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.

Roth AJ, Ooi JD, Hess JJ, van Timmeren MM, Berg EA, Poulton CE, McGregor J, Burkart M, Hogan SL, Hu Y, Winnik W, Nachman PH, Stegeman CA, Niles J, Heeringa P, Kitching AR, Holdsworth S, Jennette JC, Preston GA, Falk RJ.

J Clin Invest. 2013 Apr;123(4):1773-83. doi: 10.1172/JCI65292. Epub 2013 Mar 15.

20.

Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis.

Karasawa R, Kurokawa MS, Yudoh K, Masuko K, Ozaki S, Kato T.

Clin Exp Immunol. 2010 Sep;161(3):459-70. doi: 10.1111/j.1365-2249.2010.04218.x.

Supplemental Content

Support Center